MTCM
DMAQR

Mint Tower Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Mint Tower Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-194,190
Closed -$58K – 241
2023
Q4 		$58K Hold
194,190
– – 0.01% 118
2023
Q3 		$68K Hold
194,190
– – 0.01% 188
2023
Q2 		$31K Hold
194,190
– – ﹤0.01% 186
2023
Q1 		$28K Hold
194,190
– – ﹤0.01% 204
2022
Q4 		$12K Hold
194,190
– – ﹤0.01% 313
2022
Q3 		$8K Hold
194,190
– – ﹤0.01% 444
2022
Q2 		$21K Hold
194,190
– – ﹤0.01% 374
2022
Q1 		$35K Hold
194,190
– – ﹤0.01% 305
2021
Q4 		$62K Buy
+194,190
New +$61.4K 0.01% 313

Mint Tower Capital Management's DMAQR Position: Q1 2024 in Review

Mint Tower Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 194,190 shares — an estimated $58K sold.

Mint Tower Capital Management first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $68K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

  • Mint Tower Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
  • Mint Tower Capital Management sold 194,190 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $58K.
  • Mint Tower Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
  • Mint Tower Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $68K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Mint Tower Capital Management's 13F filing for Q1 2024, filed 14 May 2024.